Journals shouldn't accept ads: article

Share this article:
An article in PLoS Medicine called for medical journals to reject ads from drug companies, saying they compromise the objectivity of journals.

The article, co-authored by Georgetown University Medical Center professor and HRT critic Adriane Fugh-Berman, examined ads in nine medical journals, concluding they were “unreliable sources of information, since they ‘educate' physicians to prescribe the newest, most expensive drugs (which may not be superior to existing, less expensive alternatives).” Publishers could replace the lost income with consumer products advertising, the authors said. 

PLoS Medicine, a nonprofit, does not accept drug ads.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.